Troglitazone's effect on lipoprotein(a) levels. [electronic resource]
- Diabetes care May 1999
- 859-60 p. digital
Publication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't
0149-5992
10.2337/diacare.22.5.859a doi
Chromans--therapeutic use Diabetes Mellitus, Type 2--blood Female Follow-Up Studies Humans Hypoglycemic Agents--therapeutic use Lipoprotein(a)--blood Male Middle Aged Thiazoles--therapeutic use Thiazolidinediones Time Factors Troglitazone